questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Chimiokines
Chimiokines CXC
Chimiokines CXC : Questions médicales fréquentes
Termes MeSH sélectionnés :
Contraindications, Procedure
Diagnostic
5
Chimiokines
Tests de laboratoire
Maladies auto-immunes
Inflammation
Biopsie
Immunohistochimie
Symptômes
5
Système nerveux
Inflammation cérébrale
Psoriasis
Maladies cutanées
Maladies inflammatoires de l'intestin
Symptômes digestifs
Prévention
5
Hygiène de vie
Gestion du stress
Alimentation
Antioxydants
Exercice physique
Santé immunitaire
Stress chronique
Inflammation
Traitements
5
Thérapies biologiques
Inhibiteurs
Corticostéroïdes
Inflammation
Traitements anti-inflammatoires
Symptômes inflammatoires
Essais cliniques
Traitements
Complications
5
Maladies auto-immunes
Infections chroniques
Cicatrisation
Inflammation
Maladies cardiovasculaires
Risque
Sclérose en plaques
Alzheimer
Facteurs de risque
5
Infections
Expression génique
Vieillissement
Inflammation
Diabète
Maladies métaboliques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chimiokines CXC : Questions médicales les plus fréquentes",
"headline": "Chimiokines CXC : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chimiokines CXC : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-09",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chimiokines CXC"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chimiokines",
"url": "https://questionsmedicales.fr/mesh/D018925",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines",
"code": {
"@type": "MedicalCode",
"code": "D018925",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL1",
"alternateName": "Chemokine CXCL1",
"url": "https://questionsmedicales.fr/mesh/D054360",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL1",
"code": {
"@type": "MedicalCode",
"code": "D054360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL16",
"alternateName": "Chemokine CXCL16",
"url": "https://questionsmedicales.fr/mesh/D000075743",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL16",
"code": {
"@type": "MedicalCode",
"code": "D000075743",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL5",
"alternateName": "Chemokine CXCL5",
"url": "https://questionsmedicales.fr/mesh/D054365",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL5",
"code": {
"@type": "MedicalCode",
"code": "D054365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL6",
"alternateName": "Chemokine CXCL6",
"url": "https://questionsmedicales.fr/mesh/D054427",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL6",
"code": {
"@type": "MedicalCode",
"code": "D054427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL9",
"alternateName": "Chemokine CXCL9",
"url": "https://questionsmedicales.fr/mesh/D054370",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL9",
"code": {
"@type": "MedicalCode",
"code": "D054370",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL10",
"alternateName": "Chemokine CXCL10",
"url": "https://questionsmedicales.fr/mesh/D054357",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL10",
"code": {
"@type": "MedicalCode",
"code": "D054357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL11",
"alternateName": "Chemokine CXCL11",
"url": "https://questionsmedicales.fr/mesh/D054371",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL11",
"code": {
"@type": "MedicalCode",
"code": "D054371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL12",
"alternateName": "Chemokine CXCL12",
"url": "https://questionsmedicales.fr/mesh/D054377",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL12",
"code": {
"@type": "MedicalCode",
"code": "D054377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL13",
"alternateName": "Chemokine CXCL13",
"url": "https://questionsmedicales.fr/mesh/D054382",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL13",
"code": {
"@type": "MedicalCode",
"code": "D054382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur-4 plaquettaire",
"alternateName": "Platelet Factor 4",
"url": "https://questionsmedicales.fr/mesh/D010978",
"about": {
"@type": "MedicalCondition",
"name": "Facteur-4 plaquettaire",
"code": {
"@type": "MedicalCode",
"code": "D010978",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines CXC",
"alternateName": "Chemokines, CXC",
"code": {
"@type": "MedicalCode",
"code": "D019743",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Amin Ullah",
"url": "https://questionsmedicales.fr/author/Amin%20Ullah",
"affiliation": {
"@type": "Organization",
"name": "Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Bairong Shen",
"url": "https://questionsmedicales.fr/author/Bairong%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Gholamhossein Hassanshahi",
"url": "https://questionsmedicales.fr/author/Gholamhossein%20Hassanshahi",
"affiliation": {
"@type": "Organization",
"name": "Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Dept. of Hematology, Faculty of Biomed, Biomedical Sciences, Kerman University of Medical Sciences, Kerman, Iran."
}
},
{
"@type": "Person",
"name": "Mojgan Noroozi Karimabad",
"url": "https://questionsmedicales.fr/author/Mojgan%20Noroozi%20Karimabad",
"affiliation": {
"@type": "Organization",
"name": "Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: mojgan.noroozi@yahoo.com."
}
},
{
"@type": "Person",
"name": "Tracy M Handel",
"url": "https://questionsmedicales.fr/author/Tracy%20M%20Handel",
"affiliation": {
"@type": "Organization",
"name": "Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "National Consensus on Contraindications for Corneal Donation for Transplantation in Switzerland.",
"datePublished": "2024-04-23",
"url": "https://questionsmedicales.fr/article/38653295",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2211-9614"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Severe Thoracic Trauma Indications and Contraindications for Non-operative and Operative Treatment Strategies].",
"datePublished": "2024-08-07",
"url": "https://questionsmedicales.fr/article/39111302",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2348-0638"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Ross Procedure in Adolescence and Beyond: Are There Still Contraindications?",
"datePublished": "2022-12-29",
"url": "https://questionsmedicales.fr/article/36842798",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.pcsu.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Should a Narrow Corridor Be a Contraindication for Performing Oblique Lateral Interbody Fusion Procedure or Not?",
"datePublished": "2023-11-14",
"url": "https://questionsmedicales.fr/article/37962023",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/21925682231216049"
}
},
{
"@type": "ScholarlyArticle",
"name": "Are relative contraindications for unicompartmental knee replacements in medial compartment osteoarthritis really contraindications?",
"datePublished": "2024-05-23",
"url": "https://questionsmedicales.fr/article/38828470",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jor.2024.05.014"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chimiokines",
"item": "https://questionsmedicales.fr/mesh/D018925"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chimiokines CXC",
"item": "https://questionsmedicales.fr/mesh/D019743"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chimiokines CXC - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chimiokines CXC",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chimiokines CXC",
"description": "Comment diagnostiquer une dysrégulation des chimiokines CXC ?\nQuels tests sont utilisés pour mesurer les chimiokines CXC ?\nLes chimiokines CXC sont-elles liées à des maladies spécifiques ?\nPeut-on détecter les chimiokines CXC dans les biopsies ?\nLes niveaux de chimiokines CXC varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Contraindications,+Procedure#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chimiokines CXC",
"description": "Quels symptômes sont associés à une surproduction de chimiokines CXC ?\nLes chimiokines CXC peuvent-elles causer des symptômes respiratoires ?\nComment les chimiokines CXC affectent-elles le système nerveux ?\nLes chimiokines CXC sont-elles liées à des symptômes cutanés ?\nPeut-on observer des symptômes digestifs liés aux chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Contraindications,+Procedure#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chimiokines CXC",
"description": "Peut-on prévenir les maladies liées aux chimiokines CXC ?\nL'alimentation influence-t-elle les chimiokines CXC ?\nL'exercice physique affecte-t-il les niveaux de chimiokines CXC ?\nLe tabagisme influence-t-il les chimiokines CXC ?\nLe stress chronique affecte-t-il les chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Contraindications,+Procedure#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chimiokines CXC",
"description": "Quels traitements ciblent les chimiokines CXC ?\nLes corticostéroïdes affectent-ils les chimiokines CXC ?\nComment les inhibiteurs de chimiokines CXC fonctionnent-ils ?\nLes traitements anti-inflammatoires influencent-ils les chimiokines CXC ?\nY a-t-il des essais cliniques sur les chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Contraindications,+Procedure#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chimiokines CXC",
"description": "Quelles complications peuvent survenir avec des niveaux élevés de chimiokines CXC ?\nLes chimiokines CXC sont-elles impliquées dans le cancer ?\nComment les chimiokines CXC affectent-elles la cicatrisation des plaies ?\nLes maladies cardiovasculaires sont-elles liées aux chimiokines CXC ?\nLes chimiokines CXC peuvent-elles causer des troubles neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Contraindications,+Procedure#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chimiokines CXC",
"description": "Quels facteurs de risque augmentent les niveaux de chimiokines CXC ?\nLes infections peuvent-elles influencer les chimiokines CXC ?\nL'exposition à des polluants affecte-t-elle les chimiokines CXC ?\nLe vieillissement influence-t-il les chimiokines CXC ?\nLes maladies métaboliques sont-elles liées aux chimiokines CXC ?",
"url": "https://questionsmedicales.fr/mesh/D019743?mesh_terms=Contraindications,+Procedure#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des chimiokines CXC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines peuvent aider à évaluer les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer les chimiokines CXC ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages ELISA et les tests multiplex sont couramment utilisés pour mesurer les chimiokines."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles liées à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent associées à des maladies inflammatoires et auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les chimiokines CXC dans les biopsies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chimiokines peuvent être détectées dans les tissus par immunohistochimie."
}
},
{
"@type": "Question",
"name": "Les niveaux de chimiokines CXC varient-ils selon l'âge ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de chimiokines peuvent varier avec l'âge et l'état de santé général."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une surproduction de chimiokines CXC ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent inflammation, douleur, fatigue et troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC peuvent-elles causer des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans des maladies respiratoires comme l'asthme et la BPCO."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CXC affectent-elles le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent contribuer à des troubles neurologiques en modulant l'inflammation cérébrale."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles liées à des symptômes cutanés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être impliquées dans des maladies cutanées inflammatoires comme le psoriasis."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes digestifs liés aux chimiokines CXC ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent jouer un rôle dans des maladies inflammatoires de l'intestin."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux chimiokines CXC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène de vie et la gestion du stress peuvent aider à prévenir certaines maladies."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les chimiokines CXC ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut réduire l'inflammation et les chimiokines."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il les niveaux de chimiokines CXC ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler les niveaux de chimiokines et améliorer la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les chimiokines CXC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente les niveaux de chimiokines et contribue à l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress chronique affecte-t-il les chimiokines CXC ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter l'expression des chimiokines et aggraver l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les chimiokines CXC ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques et des inhibiteurs de chimiokines sont en développement."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils les chimiokines CXC ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'expression des chimiokines CXC dans l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment les inhibiteurs de chimiokines CXC fonctionnent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils bloquent les récepteurs des chimiokines, réduisant ainsi l'inflammation et la migration cellulaire."
}
},
{
"@type": "Question",
"name": "Les traitements anti-inflammatoires influencent-ils les chimiokines CXC ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent moduler les niveaux de chimiokines et améliorer les symptômes inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques sur les chimiokines CXC ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant les chimiokines CXC."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des niveaux élevés de chimiokines CXC ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies auto-immunes, des infections chroniques et des cancers."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC sont-elles impliquées dans le cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent favoriser la progression tumorale et la métastase dans certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CXC affectent-elles la cicatrisation des plaies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut retarder la cicatrisation en exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées aux chimiokines CXC ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de chimiokines sont associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CXC peuvent-elles causer des troubles neurologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont impliquées dans des troubles comme la sclérose en plaques et l'Alzheimer."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque augmentent les niveaux de chimiokines CXC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et le stress chronique sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles influencer les chimiokines CXC ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections aiguës et chroniques peuvent augmenter l'expression des chimiokines."
}
},
{
"@type": "Question",
"name": "L'exposition à des polluants affecte-t-elle les chimiokines CXC ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des polluants environnementaux peut augmenter les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Le vieillissement influence-t-il les chimiokines CXC ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner une augmentation des niveaux de chimiokines et de l'inflammation."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques sont-elles liées aux chimiokines CXC ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent augmenter les niveaux de chimiokines et l'inflammation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Publications dans "Chimiokines CXC" :
4 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Publications dans "Chimiokines CXC" :
3 publications dans cette catégorie
Affiliations :
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran; Dept. of Hematology, Faculty of Biomed, Biomedical Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Publications dans "Chimiokines CXC" :
3 publications dans cette catégorie
Affiliations :
Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: mojgan.noroozi@yahoo.com.
Publications dans "Chimiokines CXC" :
3 publications dans cette catégorie
Affiliations :
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, USA.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Departments of Biological Sciences and of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.
Present address: Dept. of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Departments of Biological Sciences and of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning Province, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Aesthetic Medicine, Medical University of Bialystok, 15-267 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Division of Cardiology, Department of Internal Medicine, University of Patras Medical School, 26500 Patras, Greece.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Intensive Care Unit, Patras University Hospital, 26500 Patras, Greece.
Publications dans "Chimiokines CXC" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiology, University Hospital of South Manchester, NHS Foundation Trust, Manchester M23 9LT, UK.
Publications dans "Chimiokines CXC" :
To establish a national consensus on contraindications for corneal donation for transplantation in Switzerland....
Swisstransplant (SWT), the Swiss national foundation coordinating tissue and organ donations, convened a working group consisting of six national corneal surgeons and eye bankers and donation experts ...
From March 2021 to November 2021, the study group held six meetings and created a standardized minimal contraindication list for corneal donation in Switzerland. Thanks to this list, SWT has created a...
Given that corneal transplantation is the most commonly performed transplantation, establishing a consensus on contraindications is crucial for recipient safety. The creation of a consensus on contrai...
Severe thoracic trauma can occur as a penetrating or blunt mono-injury or as part of a polytrauma. Almost half of all severely injured patients documented in the TraumaRegister DGU were diagnosed with...
The Ross procedure is an excellent operation to treat children and adults with aortic valve disease. Compared to prosthetic aortic valve replacement, it provides important clinical benefits in terms o...
Retrospective study....
We investigated the effect of corridor width on the postoperative outcomes of patients who underwent the OLIF procedure....
Patients who underwent OLIF surgery, which included L4-5, between 2015 and 2021 were retrospectively studied. The patients were divided into three groups by the width of the corridor: not more than 10...
A total of 81 patients were included. There were no significant differences in VAS leg and back pain scores, ODI scores, or complications between each group. The radiographic findings, including cage ...
The width of oblique corridor does not affect clinical outcomes, complications, or radiographic findings, including position of the cage, anterior and posterior disc height, segmental angle, and foram...
Medial unicompartment knee replacement (UKR) is performed for isolated medial compartment osteoarthritis. Understanding the factors influencing functional outcomes helps patient selection and outcomes...
A retrospective review of a prospectively collected database was performed. Inclusion criteria were medial UKR for medial compartment OA. The exclusion criteria were age <16, revision procedures and l...
159 UKR procedures were identified in 155 patients. 116 procedures carried out on 111 patients had follow up at > 2 years. At 5 years there were 14 patients had OKS recorded. There was no statistical ...
BMI maybe an important patient factor in predicting post operative OKS at 2-5 years. This is beneficial to surgeons for patient selection in medial UKR. Patellofemoral wear doesn't appear to impact on...
This review summarizes the current and emerging indications, contraindications, and evaluation for TIPS. In the last three decades of use, there have been substantial changes and progress in this fiel...
Recent findings have rapidly expanded the indications for TIPS, including emerging uses in hepatorenal syndrome, hepatopulmonary syndrome and before abdominal surgery. The widespread use of controlled...
Patellofemoral arthroplasty (PFA) is emerging as an attractive alternative to total knee arthroplasty (TKA) for isolated patellofemoral-osteoarthritis (PF-OA) for selected patients. The success of PFA...
Undergoing a major surgery within 14 days is considered a contraindication for intravenous alteplase. However, there is no consensus as to what qualifies as major surgery or an invasive procedure. Occ...
Rheumatoid arthritis (RA) has historically been considered a contraindication for unicompartmental knee arthroplasty (UKA). However, the widespread use of disease-modifying antirheumatic drugs has sub...
Patients undergoing UKA from 2010 to 2021 were identified in an administrative claims database (n = 105,937) using Current Procedural Terminology code 27446. All patients who underwent UKA who had a d...
Among the 1,422 patients who had a UKA and a diagnosis of RA, 37 patients (2.6%) underwent conversion to TKA within 2 years, and 48 patients (3.4%) underwent conversion to TKA at any point. In compari...
Patients who had RA and underwent UKA did not have an increased risk of revision to TKA compared to those who did not have RA. This may indicate that modern management of RA could allow for expanded U...
Laparoscopic cholecystectomy (LC) is one of the most commonly performed surgical procedures worldwide. A previous abdominal operation is not considered a significant risk factor for conversion to open...